Latest News
Daily cannabis news and breaking stories from markets, policy, and medical sectors worldwide.
Latest News · page 6
- Medical Cannabis
Vertanical Secures Milestone FDA Breakthrough Designation for Cannabis Pain Drug Ahead of Imminent European Launch
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in prime position to become the first FDA-approved cannabis-derived medicine for pain, and only the second such approval since Epidiolex in 2018.
- Industry Trends
Cannabis Europa London 2026: Key Insights, Day 2
Live Cannabis Europa 2026 London, UK From Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes Arjan Roskam, Green House Genetics; Dave Auger, Big League Genetics; Adele Hollman, Sanity Group; moderated by Alex Fraser, Grow Group Telemedicine in Germany: Maturity, Regulation and What Comes Next Kristine Lütke, 365 Sherpas GmbH; Dirk Heitepriem, German Cannabis…
- Industry Trends
Cannabis Europa London 2026 – Key Insights, Day 1
Live Cannabis Europa 2026 London, UK Cannabis Europa London is back at The Barbican Centre for two days of conversations with global cannabis leaders, policymakers, industry analysts and patient representatives, and, as ever, the sun has shown up.
- Press releases
Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026
Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), today announced its participation in Cannabis Europa London 2026, one of Europe’s leading forums for medical cannabis policy, science, and regulation.
- Press releases
Boxer Derek Chisora Reveals He Is Using Prescribed Medical Cannabis After 50 Fights to Combat Chronic Pain
Former heavyweight boxing contender Derek Chisora has revealed he is using prescribed medical cannabis to manage chronic pain following more than 20 years in professional boxing.
- US & Canada
DOJ Sues TerrAscend for $8.3m in First Known 280E Refund Clawback
The US Department of Justice has filed a federal lawsuit seeking $8.3m plus interest from New Jersey-based cannabis multistate operator TerrAscend (TSX: TSND), in what appears to be the first known instance of the government attempting to recover 280E tax refunds made proactively by a cannabis company.
- CBD Market
CBD Is A ‘Reproductive Toxicant’ Say The EU In A Major Blow to Industry
THE European Union looks set to determine that cannabidiol is a ‘human reproductive toxicant’ in a move which could wipe out the continent’s CBD cosmetic sector and seriously damage the supplements one.
- Adult-Use
Is The New Government Set To End Hungary’s Hostility To Drugs?
IT’S been a while since Hungarian cannabis advocates were able to inhale a dose of optimism, but maybe that time is now.
- US & Canada
‘Not Immediately Compliant’: What the CRS Says America’s Rescheduling Order Actually Delivers
Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this route have hung over the industry.
- Pharmaceutical
German Distributor Fette Pharma Emerges From Restructuring Under New Investor Leadership
German medicinal cannabis distributor Fette Pharma GmbH has reported the successful completion of a strategic restructuring, almost seven months after an investor consortium led by entrepreneur Jörg Löser acquired the Egelsbach-based company in September 2025.
- Industry Trends
DEA’s Schedule III Cannabis Order: A Free-For-All for Telehealth Platforms, or the Perfect Setup for the Entire Industry?
As the industry’s (more than justified) excitement over last week’s rescheduling announcement begins to subside, the regulatory reality is settling in.
- Industry Trends
Cannabis Europa London 2026: The First Major Gathering Since Rescheduling Changed the Game
For many, last week’s rescheduling announcement threw a spanner in the works.
